Each article is created without any external influence. When you use our provided links to buy products, we receive a commission as an affiliate. To understand how we generate revenue, please read our advertising disclaimer.
Fitness made for you
PT-designed routines and recipes.
Get real results without the high price tag.
In 2021, 3.71 million deaths were caused by being overweight and obese. Furthermore, it’s estimated that 1.31 billion people worldwide will develop type 2 diabetes by 2050.
These stats reinforce that current education and preventive measures are not working. With this, the need to develop effective weight loss medications increases.
As the health and wellness landscape continues to innovate, glucagon-like peptide 1 agonists, or GLP-1 medications, are gaining popularity. The initial scientific success of GLP-1 medications has put them at the forefront of current research focus. The GLP-1 market is estimated to reach USD 63.6 billion by 2032, with no signs of it slowing down.
Several providers are now offering GLP-1 medication. To help you navigate the exciting but vastly growing industry, we’ve reviewed the seven best GLP-1 providers in 2025.
What Are The Top GLP-1 Providers?
- Enhance.MD – Editor’s Choice
- Mochi Health – Best Well-Rounded Provider
- Ro – Best FDA-Approved Provider
- Direct Meds – Best Compounded Provider
- Henry Meds – Best Variety Compounded Provider
- PlushCare – Best Provider For Local Pharmacies
- Noom Med – Best Provider With Psychological Coaching
Best GLP-1 Providers In 2025
At Endomondo, we’ve done the hard work for you. These are our seven best GLP-1 providers to consider using in 2025.
Enhance.MD
Enhance.MD is an American telehealth provider that specializes in GLP-1 and GIP receptor agonist medications. The brand offers several medically supervised weight loss programs, with nutritional coaching and education content.
- A comprehensive weight loss program.
- Transparent monthly GLP-1 plans with no hidden costs.
- Integrated nutritional coaching and educational programs.
- No insurance coverage.
- Only offers compounded medications.
Enhance MD offers a comprehensive telehealth weight loss service. Part of this includes supplying cheaper compounded GLP-1 medications. These are custom-made by licensed professionals to meet patient needs. However, they are not Food and Drug Administration or FDA approved.
The available medications include Semaglutide and Tirzepatide. Semaglutide has excellent research backing as a GLP-1 medication, while tirzepatide is a newer drug that’s thought to be more effective.
Each plan includes a month’s worth of medication, ongoing provider support, and metabolic lab testing every six months. Furthermore, you get access to nutritional coaching and educational content on the platform. With this, they offer some of the best GLP-1 subscription services out of our top seven providers.
The price range of USD 212–323 per month is fairly well-priced for both medications. You also get discounts for longer-term plans, with good transparency regarding extra fees. If you’re looking for a well-rounded weight loss medication provider, Enhance is one of the best GLP-1 programs.
Key features | Medications offered | Pricing | Who is it best for |
---|---|---|---|
Compounded medications Nutritional and wellness coaching Educational resources | Compounded Semaglutide Compounded Tirzepatide | USD 79 membership fee USD 212–323 (Depending on medication) | Those looking for comprehensive weight loss solutions |
Mochi Health
Mochi Health is an American telehealth company providing personalized weight management programs. It offers several GLP-1 medications, including FDA-approved and compounded versions. The brand combines medical treatments with nutritional guidance and lifestyle coaching.
- Offers affordable and personalized weight loss plans.
- Provides education resources and nutritional coaching.
- Accepts insurance and offers insurance assistance.
- Offers 24/7 customer support via email, phone, and live chat.
- The insurance coverage may be inconsistent with some of their medications.
- Some users have reported delays in medications and communication issues.
Mochi Health offers FDA-approved Semaglutide, Tirzepatide, and Liraglutide alongside oral Semaglutide if you don’t like injections. Whether you’re using them alongside the best fat burners or as a stand-alone treatment, Mochi Health is a great provider.
The USD 79 monthly membership fee gives you access to virtual consultations with board-certified providers, educational resources, and lifestyle coaching. As an insurance-friendly provider, the final price depends on your insurance. However, Mochi Health provides great assistance if you need a helping hand, and clearly states the extra fees.
Overall, Mochi Health is one of the top telemedicine platforms offering injectables and oral medications. The added support and education alongside the user-friendly platform make them a fantastic choice.
Key features | Medications offered | Pricing | Who is it best for |
---|---|---|---|
FDA-approved medications Compounded medications Oral medications Educational resources Lifestyle coaching | FDA-approved Semaglutide FDA-approved Tirzepatide FDA-approved Liraglutide Oral Semaglutide | USD 79 membership fee Medication pricing depends on insurance | Those looking for FDA-approved or compounded medications Those with insurance assistance Those looking for budget-friendly options |
Ro
Ro is an American telehealth provider that offers the Ro Body Program, a comprehensive weight loss solution. This includes FDA-approved brand-name GLP-1 and GIP medications alongside nutritional coaching and educational resources.
- The brand focuses solely on FDA-approved GLP-1 prescriptions online.
- Accepts insurance and offers insurance assistance.
- The Ro Body Program offers comprehensive weight loss management.
- The FDA medications are extremely expensive.
- Large up-front membership fee.
Ro’s Body Program focuses solely on FDA-approved medications such as Ozempic, Wegovy, and Zepbound. In addition, it offers health coaching, educational resources, and progress tracking. This makes it one of the best GLP-1 weight loss programs on our top seven list.
While the up-front costs are quite high, you’re getting access to proven medications from high-quality pharmacies. You pay USD 45 for the first month, followed by a USD 145 monthly membership fee. Following this, the cost depends on your insurance coverage.
The medication costs are extremely high. However, the fact that Ro accepts insurance and provides assistance makes it an attractive option. If you’re looking for FDA-approved medication covered by insurance, Ro is one of the best GLP-1 suppliers.
In Ro’s integrated platform, you can perform the health assessments, get the monthly renewals, and use the messaging service. This connects you to registered healthcare providers who will be happy to discuss your treatment plan.
Key features | Medications offered | Pricing | Who is it best for |
---|---|---|---|
FDA-approved medications Health coaching Educational resources Progress tracking | FDA-approved Semaglutide FDA-approved Tirzepatide FDA-approved Liraglutide | USD 45 assessment fee USD 145 monthly membership Medication pricing depends on insurance | Those looking for FDA-approved medications Those with insurance |
Direct Meds
Direct Meds specializes in compounded GLP-1 weight loss medications, including injectables and oral drops. The US-based brand offers subscription-free plans with transparent pricing. They aim to deliver accessible weight loss medications to all customers.
- Offers easily accessible treatment without in-person appointments.
- Offers testosterone therapy as an additional treatment.
- All-inclusive plans include medication, support, and delivery.
- Doesn’t accept insurance.
- Only uses compounded injectable GLP-1 medications.
If you’re on a budget and can’t quite afford the FDA-approved versions, compounded medications may be your best option. Bear in mind that these are not regulated and carry their risks. However, if you’re okay with this, Direct Meds is one of the most affordable GLP-1 providers.
The brand focuses solely on compounded medications that come at budget-friendly price points. These include injectable Semaglutide, Tirzepatide, and oral Semaglutide. Unfortunately, Direct Meds offers GLP-1 without insurance coverage. However, at USD 249–497 per month, they’re much more affordable and have no hidden fees.
After the initial health questionnaire, you have a brief medical review before the medication is swiftly delivered. Alongside the medication, you get telehealth consultations and educational resources. Direct Meds is a great option for those looking for a quick and simple compounded medication option.
Key features | Medications offered | Pricing | Who is it best for |
---|---|---|---|
Compounded medications Oral medications Educational resources | Compounded Semaglutide Compounded Tirzepatide Sublingual Semaglutide | USD 249–497 (Depending on medication) | Those looking for compounded medications Those looking for oral medications Those who want transparent pricing plans |
Henry Meds
Henry Meds offers several compounded GLP-1 and GIP weight loss medications, which come with personalized care plans. The brand focuses on transparent pricing, accessible plans, and overall convenience.
- Allows you to switch providers during treatment.
- Included regular one-on-one telehealth meetings.
- Uses licensed US clinicians.
- 30-day full refund available.
- Only compounded medications are offered.
- Doesn’t accept insurance coverage.
- Not available in all US states.
Henry Meds prides itself on providing convenient, flexible telehealth services at affordable prices. It offers Semaglutide, Tirzepatide, and Liraglutide. Furthermore, it has an oral Semaglutide option for those who don’t like injectables.
The medication process is clearly explained, with a physician guiding you every step of the way. You have the medical assessments and virtual consultations with licensed practitioners. Following this, the medication is delivered directly to your door.
Being a long-term healthcare provider, Henry Meds offers flexible shipping options that range from 60–90 days. You also have a 30-day satisfaction guarantee, meaning you can change your mind if you’re unhappy with the service.
Key features | Medications offered | Pricing | Who is it best for |
---|---|---|---|
Compounded weight loss medications Testosterone therapy | Compounded Semaglutide Compounded Tirzepatide Compounded oral Semaglutide Compounded Liraglutide | USD 99–249 (Depending on medication) | Those looking for compounded weight loss medication Those looking for additional testosterone therapy |
PlushCare
PlushCare is an American telehealth company offering comprehensive weight loss solutions. This included brand-name and compounded medications alongside weight management plans and nutritional coaching.
- Uses board-certified doctors who specialize in weight management.
- Includes weight management plans and nutritional coaching.
- Local pharmacies can be used for the prescriptions.
- Some of the GLP-1 medications may not be covered by insurance.
PlushCare offers personalized weight loss programs made by board-certified physicians. The constant monitoring means PlushCare can continuously adjust your treatment as you achieve your weight loss goals.
What’s great about PlushCare is the fact that it uses local licensed and regulated pharmacies. It provides FDA-approved and compounded weight loss drugs from your local area, if possible.
While you have to pay the monthly USD 27.99 membership fee, PlushCare accepts insurance coverage. What’s even better is the fact that it’ll assist with the insurance process. With this, you have an affordable treatment provider that cares about your needs.
Once you’re on board, you get access to the medication, nutritional coaching, and weight management plans. The process is clearly explained before purchasing, with a dedicated physician guiding you. If you’re looking for an integrated GLP-1 provider that goes the extra mile, PlushCare ticks all the boxes.
Key features | Medications offered | Pricing | Who is it best for |
---|---|---|---|
FDA-approved medications Compounded medications Nutritional coaching Weight management plans At-home lab testing | FDA-approved Semaglutide FDA-approved oral Semaglutide FDA-approved Tirzepatide FDA-approved Liraglutide Compounded Semaglutide Compounded Tirzepatide | USD 27.99 (Membership fee) Medication pricing depends on insurance coverage | Those looking for FDA-approved and compounded weight loss medications Those wanting additional weight loss management and nutritional guidance Those needed at-home lab testing |
Noom Med
Noom Med is a digital telehealth company focusing on behavioral coaching and the mindset behind weight loss. It does this while offering several brand-name and compounded GLP-1 and GIP medications.
- Focuses on behavioural change through psychological coaching.
- Accepts insurance and provides insurance assistance.
- The daily care team includes health coaches and clinicians.
- Two built-in subscription fees.
- Only available in 35 US states.
Last on our top seven list is Noom Med, a telehealth provider that offers something slightly different. Alongside the medication, you have integrated behavioral coaching and psychological guidance. In terms of the medications, Noom Med offers FDA-approved and compounded Semaglutide and Tirzepatide.
With Noom Med, you can choose the type of support you need. This includes a personal coach, group support, or a full-on plan. The Noom app tracks your food intake while integrating with your health coach and psychology lessons. It’s our best provider with psychological coaching.
When working with Noom Med, you know the medication is coming from a legitimate pharmacy. This is because you’re required to choose a pharmacy that you know and trust. While this requires a little more work, it adds a personal element that some will prefer.
The process for getting the medication is clearly explained, with transparent pricing that’s based on your insurance package. If you’re looking for one of the most well-rounded GLP-1 telehealth providers, this is the one to choose.
Key features | Medications offered | Pricing | Who is it best for |
---|---|---|---|
FDA-approved weight loss medications Compounded weight loss medications Behavioural coaching Psychological guidance Educational resources | FDA-approved Semaglutide FDA-approved Tirzepatide Compounded Semaglutide | USD 42–49 membership fee Medication prices vary based on insurance | Those looking for behavioural coaching and psychological guidance Those looking for FDA-approved and compounded weight loss medications |
Best GLP-1 Suppliers
Provider | Medications offered | Price range | Insurance | Additional program features |
---|---|---|---|---|
Enhance.MD | Compounded Semaglutide Tirzepatide | USD 249/month or USD 212/month (Annual) USD 379/month or USD 323/month (Annual) | No | Nutrition and wellness coaching Educational content Metabolic laboratory testing |
Mochi Health | Ozempic (Semaglutide) Wegovy (Semaglutide) Compounded Semaglutide Mounjaro (Tirzepatide) Zepbound (Tirzepatide) Saxenda (Liraglutide) Victoza (Liraglutide) Rybelsus (Oral Semaglutide) | USD 79 membership fee Medication costs depend on insurance coverage | Yes — Insurance assistance | |
Ro | Ozempic (Semaglutide) Wegovy (Semaglutide) Zepbound (Tirzepatide) Saxenda (Liraglutide) | USD 45 assessment and medical review fee USD 145 monthly membership Ozempic (USD 900–1000 per month) Zepbound (USD 349–499 per month) Exact cost depends on insurance | Yes — Insurance assistance | Health coaching Educational resources Progress tracking Metabolic testing |
Direct Meds | Compounded Semaglutide Compounded Tirzepatide Sublingual Semaglutide drops | USD 297/month USD 497/month USD 249/month | No | Educational resources |
Henry Meds | Compounded Semaglutide Compounded Oral Semaglutide Compounded oral Tirzepatide Compounded Liraglutide | USD 147 (First month), then USD 247 afterwards USD 149 (First month), then USD 249 afterwards USD 249 (First month), then USD 349 afterwards USD 99 (First month), then USD 149 afterwards | No | Testosterone therapy |
PlushCare | Ozempic (Semaglutide) Wegovy (Semaglutide) Rybelsus (Oral Semaglutide) Mounjaro (Tirzepatide) Victoza (Liraglutide) Compounded Semaglutide Compounded Tirzepatide | USD 27.99 (Normal membership) Price depends on insurance coverage | Yes | Weight management plans Nutritional recommendations At-home lab testing |
Noom Med | Ozempic (Semaglutide) Wegovy (Semaglutide) Zepbound (Tirzepatide) Mounjaro (Tirzepatide) Compounded Semaglutide | USD 42–49 (Monthly membership fee) Medication prices vary based on insurance | Yes | Educational resources Behavioral coaching Psychological tools |
How We Examined GLP-1 Suppliers
With the modern telehealth industry evolving, GLP-1 medications are reshaping the future of weight loss and metabolic health.
Here at Endomondo, we pride ourselves on implementing a rigorous testing process. Our team of in-house experts looked at each provider in detail.
Part of the testing process involved taking each provider through the points below. These are the ones we see as most important when finding the best GLP-1 provider for your needs.
Medical Credibility And Licensing
Prescription medicines such as GLP-1 and GIP agonists offer powerful effects on the body. They modulate blood sugar, promote weight loss, and may offer cardiovascular benefits. Because of this, they must be prescribed by a medically credible provider with the correct licensing.
We evaluated each of the providers above for their medical credibility. Within this, we checked for licensed practitioners and certified doctors. Furthermore, we checked to see if the aftercare teams had specific expertise relating to obesity and blood sugar management.
Additionally, we looked at whether the provider was licensed in all 50 states. If not, we checked to see which regions they could normally operate in. This ensured that the treatments prescribed were done using scientifically sound guidance.
Medications Offered
We looked at whether the medications offered by each provider were FDA-approved. If so, this meant that they had undergone a rigorous testing process and showed valid efficacy as a treatment option. Furthermore, this means that they have been declared safe to use, with a safe dosage established.
Alongside this, we checked to see how each provider was sourcing their medications and how they prescribed them. Knowing where to get GLP-1 medications is an important consideration when offering a high-quality service.
Furthermore, we looked at whether the providers offered brand-name or compounded medications. While the compounded ones may be more accessible, they’re not FDA-approved. This means that the quality may vary significantly.
Part of this involved looking at how transparent the provider was in disclosing the compounded medications. We checked to see if they disclosed how they’re sourced, the regulations behind them, and if they meet safety standards.
Accessibility
Having accessible medication when you need it can often be the difference between a successful program and a total failure. Whatever stage of the medication process, you shouldn’t need to overcome barriers when working with your provider. This includes when beginning treatment, receiving ongoing care, and asking for support.
We examined each provider closely to see how accessible the support was. This involved analyzing the whole process, from the initial onboarding stage to the ongoing support following the prescription. We also looked to see if each provider listed how to qualify for GLP-1 medication.
Our main considerations were as follows:
- How easy it is to get started when onboarding.
- The sign-up process and how easy it is to do.
- The waiting times for medical evaluations.
- The quality of the ongoing support.
Cost Transparency And Insurance Support
While GLP-1 medications may offer several useful benefits, they’re very expensive. Without insurance, monthly costs may total more than USD 1000. Therefore, understanding the costs involved and the insurance support process is critical.
When looking at this, we started by checking how clear each provider was with their costs. We looked to see if they clearly stated their upfront medication cost, consultation fees, laboratory fees, and follow-up care fees. Providers who detailed all costs were given higher scores.
Getting GLP-1 medications covered by insurance is a process that involves checking for eligibility and submitting the required paperwork. While some providers will help with the insurance process, others leave it up to you. Therefore, we checked each provider to see which offered the best insurance support.
Additional Program Features
It’s important to note that sustainable weight loss doesn’t just come from medication. GLP-1 medications should be used to aid weight loss rather than becoming the main method of achieving it.
For most cases, a well-organized dietary intake and consistent exercise program should be the foundation of any weight-loss strategy. Alongside this, the importance of good mental health for weight loss can not be overstated.
Some providers recognize the importance of this and integrate additional support. This may include nutrition coaching, custom workout plans, and general health education.
Benefits And Potential Side Effects Of GLP-1 Medications
GLP-1 medications are commonly prescribed to manage type 2 diabetes or as a weight-loss drug. Different medications may be injected or taken orally, depending on the chosen provider.
Benefits
These are the main proposed benefits and side effects of taking GLP-1 medications. We’ve discussed the main ones, allowing you to make an informed choice before taking them.
Significant Weight Loss
Weight loss refers to reducing body mass. This is typically done by lowering fat mass through a well-organized diet and exercise regimen to create a caloric deficit. It’s a key goal for recreational gym goers for general health and longevity.
GLP-1 medications mimic the action of GLP-1, a hormone that regulates appetite and blood sugar. This helps to reduce appetite levels and increase the feelings of fullness, reducing subsequent caloric intake.
Studies looking at GLP-1 medications and weight loss have shown decreases of approximately 15%–25% after one year. This is when combined with healthy lifestyle changes and a well-organized exercise routine.
Better Blood Sugar Control
Blood sugar control refers to the body’s ability to maintain stable glucose levels in the blood. This is the primary energy source for the body’s cells, making the maintenance of blood sugar essential. This is important for energy production and metabolic health.
Poor blood sugar control may lead to type 2 diabetes, a chronic disease characterized by high blood sugar. This is what GLP-1 medications were originally designed for. When glucose levels rise, GLP-1 increases insulin, a hormone that absorbs glucose from the blood. Furthermore, it helps slow the digestive process, meaning glucose enters the bloodstream at a slower pace.
This results in better blood sugar control and reduces the need for other medications. Beneficial symptoms may include improved energy, reduced cravings, and better metabolic health.
May Reduce Cardiovascular Disease Risk
Cardiovascular diseases refer to a group of conditions that affect the functioning of the heart and blood vessels. A common example is coronary heart disease, a condition where the blood and oxygen supply to the heart becomes limited. Risk factors include diabetes, obesity, and high cholesterol.
GLP-1 medications may help lower some of the key risk factors for cardiovascular disease. These include lowering blood pressure, reducing diabetes risk, and decreasing cholesterol levels.
This is often seen as a result of the weight loss and better blood sugar control. Semaglutide, a specific GLP-1 medication, has been FDA-approved for cardiovascular disease risk prevention. However, this is specifically for Ozempic and Wegovy.
Better Appetite Regulation
Appetite regulation is a natural bodily process that involves signaling when to eat and when to stop eating. This helps to control bodyweight and energy at natural levels for current needs and the surrounding environment. Poor appetite regulation may lead to overeating and weight gain.
The GLP-1 hormone activates brain receptors that control satiety and hunger. By mimicking this hormone, GLP-1 medications can increase feelings of fullness and reduce the desire to eat.
Potential Side Effects
Generally speaking, GLP-1 medications have a favorable safety profile. Most of the reported side effects are minor and tend to go away.
However, it’s still important to be aware of the potential side effects. These include:
- Stomach pain.
- Vomiting.
- Nausea.
- Fatigue.
- Headaches.
- Dizziness.
- Digestive Issues.
Less common but more severe side effects include:
- Gallbladder Disorders.
- Acute Pancreatitis (Pancreas Inflammation).
How To Choose The Right Provider
Choosing the right GLP-1 medication provider should involve several key factors. This ensures they’re effective, safe to use, and right for your health and wellness goals.
Goal(s)
Establishing your primary health goals should be your first consideration. This allows you to get a baseline of what you’re wanting to achieve before you can choose the best provider.
Decide on your primary health goal. This may be managing blood sugar levels, weight loss, and controlling type 2 diabetes. These are the main suggested benefits of GLP-1 medications.
Some platforms are better suited to weight loss, while others offer access to diabetes specialists and endocrinologists. A good provider should be able to look at your health history, assess your needs, and provide a personalized prescription.
If you’re unsure of your needs and what each platform can offer, a qualified healthcare professional can help. Ensure you consult with a doctor or relevant specialist through the process, whether that’s your doctor or one on the platform.
Cost Compatibility
The cost of different online GLP-1 providers can vary considerably. This can include differences in consultation fees and monthly subscriptions. Furthermore, some allow insurance coverage while others require you to pay up front.
GLP-1 medications can be expensive without insurance. Compare the cost of each provider and how much the medication offered meets your needs. Consider this alongside your budget and whether the provider works with your insurance plan.
Some providers may offer generic alternatives, pharmacy discounts, or subscription-based services. It’s important to check the effectiveness of the generic alternatives and the regulations behind them.
Convenience And Accessibility
Convenience and accessibility are two of the most important considerations. Convenience refers to the ease and simplicity of the overall process. Accessibility is the ability to access the service.
For each GLP-1 provider, consider how easy it is to get started and the availability of each service. Alongside this, look at how the refill process is handled and how simple it is to navigate.
Some online providers offer direct shipping, while others will work with local primary care providers. The right choice depends on your needs and preferences.
Support Process And Medical Oversight
The right support process ensures you’re getting the desired effect. Alongside this, it limits the chance of potential side effects that may come with taking different medications.
Choose a provider that offers ongoing medical supervision rather than a one-time provider. Some providers offer access to professionals alongside follow-up visits. Throughout the process, this means that someone will monitor your responses and make any necessary adjustments.
While some platforms will offer continuous care packages, it’s important to verify the credibility of the professionals. This can be done by looking at medical qualifications and user reviews.
Conclusion
Choosing the right GLP-1 provider is vital to ensure the correct management of your weight and metabolic health. Each of these provides access to GLP-1 medications such as Semaglutide and Tirzepatide. However, they differ in medical support, convenience, accessibility, and cost.
Overall, the best choice comes down to your personal goals and needs. Use our provider considerations as the main foundation to work from while taking each of our reviews into account.
Frequently Asked Questions
Ozempic and Wegovy are fairly similar providers, both offering Semaglutide GLP-1. Mounjaro is unique as it offers Tirzapatide, a medication that targets GLP-1 and GIP receptors. Mounjaro uses a newer medication that may be a better option.
Both medications are classed as GLP-1 receptor agonists, with Tirzepatide also acting as a GIP agonist. Switching between medications is common and relatively safe if done correctly. We recommend that you switch with the help of a qualified healthcare professional.
Wegovy is more expensive than Ozempic because of the dosage, packaging, and dispensing method. Generally speaking, Wegovy is prescribed at a higher dose and packaged using single-dose pens. Alongside this, Wegovy is specifically approved for weight loss.
Semaglutide and Tirzepatide are generally considered the most effective GLP-1 agonists for weight loss. Tirzepatide may be the better option for blood sugar control due to its dual action. However, it’s a newer, less proven medication.
Resources
Endomondo.com refrains from utilizing tertiary references. We uphold stringent sourcing criteria and depend on peer-reviewed studies and academic research conducted by medical associations and institutions. For more detailed insights, you can explore further by reading our editorial process.
- Ng, M., Emmanuela Gakidou, Lo, J., Abate, Y.H., Cristiana Abbafati, Abbas, N., Mohammadreza Abbasian, Samar Abd ElHafeez, Abdel-Rahman, W.M., Sherief Abd-Elsalam, Abdollahi, A., Meriem Abdoun, Abdulah, D.M., Rizwan Suliankatchi Abdulkader, Abdullahi, A., Abedi, A., Hansani Madushika Abeywickrama, Alemwork Abie, Aboagye, R.G. and Shady Abohashem (2025). Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. The Lancet, [online] 405(10481), pp.813–838. doi:https://doi.org/10.1016/s0140-6736(25)00355-1.
- Patil, V. (2025). GLP-1 Receptor Agonist Market Size & Analysis, 2025-2032. [online] Coherent Market Insights. Available at: https://www.coherentmarketinsights.com/market-insight/glp-1-receptor-agonist-market-4632#:~:text=Global%20GLP%2D1%20receptor%20agonist,12.3%25%20from%202025%20to%202032.
- Office (2025). U.S. Food and Drug Administration. [online] U.S. Food and Drug Administration. Available at: https://www.fda.gov/.
- Dayan, P.H., Sforzo, G., Boisseau, N., Pereira-Lancha, L.O. and Lancha, A.H. (2018). A new clinical perspective: Treating obesity with nutritional coaching versus energy-restricted diets. Nutrition, [online] 60, pp.147–151. doi:https://doi.org/10.1016/j.nut.2018.09.027.
- Liu, Q.K. (2024). Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists. Frontiers in Endocrinology, [online] 15. doi:https://doi.org/10.3389/fendo.2024.1431292.
- Hallock, R., Ufholz, K. and Patel, N. (2024). Self-Monitoring of Weight as a Weight Loss Strategy: A Systematic Review. Current Cardiovascular Risk Reports, [online] 18(11), pp.163–172. doi:https://doi.org/10.1007/s12170-024-00746-5.
- Grossmann, M., Anawalt, B.D. and Yeap, B.B. (2024). Testosterone therapy in older men: clinical implications of recent landmark trials. European Journal of Endocrinology, [online] 191(1), pp.R22–R31. doi:https://doi.org/10.1093/ejendo/lvae071.
- Luz, Y., Calvi, I.P., Marques, I.R., Cruz, S.A., Messias, E., Emanuel, P., Azevedo, H., Cardoso, R., Moura, F.A. and Vladimir Vitalievich Rafalskiy (2023). Efficacy and safety of the dual GIP and GLP-1 receptor agonist tirzepatide for weight loss: a meta-analysis of randomized controlled trials. International Journal of Obesity, [online] 47(10), pp.883–892. doi:https://doi.org/10.1038/s41366-023-01337-x.
- Mehta, A., Marso, S.P. and Neeland, I.J. (2016). Liraglutide for weight management: a critical review of the evidence. Obesity Science & Practice, [online] 3(1), pp.3–14. doi:https://doi.org/10.1002/osp4.84.
- Wong, H.J., Sim, B., Teo, Y.H., Teo, Y.N., Chan, M.Y., Yeo, L.L.L., Eng, P.C., Tan, B.Y.Q., Sattar, N., Mayank Dalakoti and Sia, C.-H. (2025). Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference for Patients With Obesity or Overweight: A Systematic Review, Meta-analysis, and Meta-regression of 47 Randomized Controlled Trials. Diabetes Care, [online] 48(2), pp.292–300. doi:https://doi.org/10.2337/dc24-1678.
- Fernanda Muñoz Obino, K., Aguiar Pereira, C. and Caron Lienert, R. (2016). Coaching and barriers to weight loss: an integrative review. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, [online] Volume 10, pp.1–11. doi:https://doi.org/10.2147/dmso.s113874.
- Zhu, B., Gostoli, S., Benasi, G., Patierno, C., Petroni, M.L., Nuccitelli, C., Marchesini, G., Fava, G.A. and Rafanelli, C. (2022). The Role of Psychological Well-Being in Weight Loss: New Insights from a Comprehensive Lifestyle Intervention. International Journal of Clinical and Health Psychology, [online] 22(1), p.100279. doi:https://doi.org/10.1016/j.ijchp.2021.100279.
- Collins, L. and Costello, R.A. (2024). Glucagon-Like Peptide-1 Receptor Agonists. [online] Nih.gov. Available at: https://www.ncbi.nlm.nih.gov/books/NBK551568/.
- A Michael Lincoff, Kirstine Brown-Frandsen, Colhoun, H.M., Deanfield, J., Emerson, S.S., Sille Esbjerg, Søren Hardt-Lindberg, G Kees Hovingh, Kahn, S.E., Kushner, R.F., Ildiko Lingvay, Oral, T.K., Michelsen, M.M., Plutzky, J., Tornøe, C.W. and Ryan, D.H. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. New England Journal of Medicine, [online] 389(24), pp.2221–2232. doi:https://doi.org/10.1056/nejmoa2307563.
- Center (2023). Drug Development & Approval Process. [online] U.S. Food and Drug Administration. Available at: https://www.fda.gov/drugs/development-approval-process-drugs.
- Aremu, T.O., Oluwole, O.E., Adeyinka, K.O. and Schommer, J.C. (2022). Medication Adherence and Compliance: Recipe for Improving Patient Outcomes. Pharmacy, [online] 10(5), p.106. doi:https://doi.org/10.3390/pharmacy10050106.
- Hu, Y., Zheng, S.-L., Ye, X.-L., Shi, J.-N., Zheng, X.-W., Pan, H.-S., Zhang, Y.-W., Yang, X.-L. and Huang, P. (2022). Cost-effectiveness analysis of 4 GLP-1RAs in the treatment of obesity in a US setting. Annals of Translational Medicine, [online] 10(3), pp.152–152. doi:https://doi.org/10.21037/atm-22-200.
- Contreras, F., Al-Najim, W. and le Roux, C.W. (2024). Health Benefits Beyond the Scale: The Role of Diet and Nutrition During Weight Loss Programmes. Nutrients, [online] 16(21), p.3585. doi:https://doi.org/10.3390/nu16213585.
- Alhalel, N., Schueller, S.M. and O’Brien, M.J. (2018). Association of changes in mental health with weight loss during intensive lifestyle intervention: does the timing matter? Obesity Science & Practice, [online] 4(2), pp.153–158. doi:https://doi.org/10.1002/osp4.157.
- Moiz, A., Filion, K.B., Tsoukas, M.A., Yu, O.HY., Peters, T.M. and Eisenberg, M.J. (2025). Mechanisms of GLP-1 Receptor Agonist-Induced Weight Loss: A Review of Central and Peripheral Pathways in Appetite and Energy Regulation. The American Journal of Medicine. [online] doi:https://doi.org/10.1016/j.amjmed.2025.01.021.
- Reiss, A.B., Gulkarov, S., Lau, R., Klek, S.P., Srivastava, A., Renna, H.A. and Leon, J.D. (2025). Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss. Biomolecules, [online] 15(3), pp.408–408. doi:https://doi.org/10.3390/biom15030408.
- Basith, A., Hashim, M.J., King, J.K., Govender, R.D., Mustafa, H. and Juma Al Kaabi (2019). Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends. Journal of Epidemiology and Global Health, [online] 10(1), pp.107–107. doi:https://doi.org/10.2991/jegh.k.191028.001.
- Nauck, M.A., Quast, D.R., Jakob Wefers and Meier, J.J. (2020). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, [online] 46, pp.101102–101102. doi:https://doi.org/10.1016/j.molmet.2020.101102.
- World (2021). Cardiovascular diseases (CVDs). [online] Who.int. Available at: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).
- Lamija Ferhatbegović, Mršić, D. and Amra Macić-Džanković (2023). The benefits of GLP1 receptors in cardiovascular diseases. Frontiers in Clinical Diabetes and Healthcare, [online] 4. doi:https://doi.org/10.3389/fcdhc.2023.1293926.
- Parmar, R.M. and Can, A.S. (2023). Physiology, Appetite And Weight Regulation. [online] Nih.gov. Available at: https://www.ncbi.nlm.nih.gov/books/NBK574539/.
- Aldawsari, M., Almadani, F.A., Almuhammadi, N., Algabsani, S., Alamro, Y. and Aldhwayan, M. (2023). The Efficacy of GLP-1 Analogues on Appetite Parameters, Gastric Emptying, Food Preference and Taste Among Adults with Obesity: Systematic Review of Randomized Controlled Trials. Diabetes, Metabolic Syndrome and Obesity, [online] Volume 16, pp.575–595. doi:https://doi.org/10.2147/dmso.s387116.
- Shetty, R., Basheer, F.T., Pooja Gopal Poojari, Girish Thunga, Chandran, V.P. and Acharya, L.D. (2022). Adverse drug reactions of GLP-1 agonists: A systematic review of case reports. Diabetes & Metabolic Syndrome Clinical Research & Reviews, [online] 16(3), pp.102427–102427. doi:https://doi.org/10.1016/j.dsx.2022.102427.
- Ghusn, W. and Hurtado, M.D. (2024). Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks. Obesity Pillars, [online] 12, p.100127. doi:https://doi.org/10.1016/j.obpill.2024.100127.
- Wong, M.Y.C., Ou, K. and Chung, P.K. (2022). Healthy Lifestyle Behavior, Goal Setting, and Personality among Older Adults: A Synthesis of Literature Reviews and Interviews. Geriatrics, [online] 7(6), p.131. doi:https://doi.org/10.3390/geriatrics7060131.
- Green, L. and Taddei-Allen, P. (2023). Shifting paradigms: Reframing coverage of antiobesity medications for plan sponsors. Journal of Managed Care & Specialty Pharmacy, [online] 29(5), pp.564–568. doi:https://doi.org/10.18553/jmcp.2023.29.5.564.
- Mattingly, T.J. and Conti, R.M. (2025). Marketing and Safety Concerns for Compounded GLP-1 Receptor Agonists. JAMA Health Forum, [online] 6(1), pp.e245015–e245015. doi:https://doi.org/10.1001/jamahealthforum.2024.5015.
- Sforzo, G.A., Gordon, N.F., Peeke, P.M. and Moore, M. (2024). Health and Well-Being Coaching Adjuvant to GLP-1 Induced Weight Loss. American Journal of Lifestyle Medicine. [online] doi:https://doi.org/10.1177/15598276241302273.
- Ryan, N. and Savulescu, J. (2025). The Ethics of Ozempic and Wegovy. Journal of Medical Ethics, [online] p.jme-2024-110374. doi:https://doi.org/10.1136/jme-2024-110374.
0 Comments